Silvercrest Asset Management Group LLC Amphastar Pharmaceuticals, Inc. Transaction History

Silvercrest Asset Management Group LLC

$14.6 Billion
Q4 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 166,814 shares of AMPH stock, worth $5.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

166,814

Previous 168,472 0.98%

Holding current value

$5.17 Million

Previous $8.18 Million 24.24%

% of portfolio

0.04%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$36.84 - $53.4 $61,080 - $88,537	-1,658 Reduced 0.98%	166,814 $6.19 Million
Q3 2024 Nov 14, 2024	SELL	$36.99 - $50.09 $40,836 - $55,299	-1,104 Reduced 0.65%	168,472 $8.18 Million
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $6.55 Million - $7.37 Million	-169,576 Reduced 50.0%	169,576 $6.78 Million
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $8.76 Million - $9.86 Million	226,724 Added 201.66%	339,152 $13.6 Million
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $1.25 Million - $1.85 Million	29,182 Added 35.06%	112,428 $4.94 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $1.2 Million - $1.72 Million	-26,401 Reduced 24.08%	83,246 $3.83 Million
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $1.62 Million - $2.64 Million	-45,221 Reduced 29.2%	109,647 $6.3 Million
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $1.91 Million - $2.59 Million	-68,290 Reduced 30.6%	154,868 $5.81 Million
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $55,804 - $62,477	-1,998 Reduced 0.89%	223,158 $6.25 Million
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $168,667 - $231,030	-6,120 Reduced 2.65%	225,156 $6.33 Million
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $310,560 - $440,873	-10,425 Reduced 4.31%	231,276 $8.05 Million
Q1 2022 May 16, 2022	SELL	$22.96 - $36.45 $2.92 Million - $4.64 Million	-127,250 Reduced 34.49%	241,701 $8.68 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $151,626 - $182,750	-8,504 Reduced 2.25%	368,951 $7.01 Million
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $1.44 Million - $1.75 Million	83,873 Added 28.57%	377,455 $7.61 Million
Q1 2021 May 17, 2021	SELL	$17.21 - $20.65 $674,890 - $809,789	-39,215 Reduced 11.78%	293,582 $5.38 Million
Q4 2020 Feb 16, 2021	BUY	$17.76 - $21.24 $920,269 - $1.1 Million	51,817 Added 18.44%	332,797 $6.69 Million
Q3 2020 Nov 16, 2020	SELL	$17.99 - $22.22 $96,066 - $118,654	-5,340 Reduced 1.87%	280,980 $5.27 Million
Q2 2020 Aug 14, 2020	SELL	$14.25 - $22.46 $71,706 - $113,018	-5,032 Reduced 1.73%	286,320 $6.43 Million
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $112,901 - $179,073	-8,918 Reduced 2.97%	291,352 $4.32 Million
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $1.18 Million - $1.43 Million	69,229 Added 29.96%	300,270 $5.79 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $4.42 Million - $5.23 Million	231,041 New	231,041 $4.58 Million

Others Institutions Holding AMPH

# of Institutions

275

Shares Held

35.1M

Call Options Held

56.2K

Put Options Held

3.5K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.52B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Amphastar Pharmaceuticals, Inc. Transaction History